Drug Trial News

RSS

Obese people may be more sensitive to pain

The obese patients showed a greater physical response to the electrical stimulation than did the non-obese people, both before and after the training session. This indicates they had a lower tolerance for the painful stimulation despite reporting, in questionnaires, that they felt no more pain than non-obese people.

1 Mar 2006

Reaction to DTaP vaccine finds no help from ibuprofen, acetaminophen

A red splotch forms where most preschoolers get their fifth, and last, shot of the acellular diphtheria-tetanus-pertussis (DTaP) vaccine, and it can last a few days.

1 Mar 2006

Physical symptoms that mark frailty often reversible

In a study to determine how older people progress through different states of frailty, researchers at Yale School of Medicine have found that the physical symptoms that mark frailty are often reversible and therefore amenable to intervention.

1 Mar 2006

Amifostine makes radiation more effective

Doctors in Brazil have concluded that the drug amifostine eases many of the most common side effects associated with patients receiving radiation therapy to treat their cancer while simultaneously making the cancer more susceptible to radiation.

1 Mar 2006

New technique provides insight into shape of DNA molecules attached to a surface

A team of researchers from Boston University has developed a new application to enable more precise measurement of the location of a fluorescent label in a DNA layer.

1 Mar 2006

Human papillomavirus the main risk factor for cervical adenocarcinoma

Human papillomavirus (HPV) was found to be the main risk factor associated with increased incidence of an unusual type of cervical cancer called cervical adenocarcinoma, according to a study in the March 1 issue of the Journal of the National Cancer Institute.

1 Mar 2006

Delayed surgical treatment may combat overtreatment of prostate cancer

Delayed surgical treatment for patients with small, low-grade prostate cancer tumors was not associated with lowered curability, according to a study in the March 1 issue of the Journal of the National Cancer Institute.

1 Mar 2006

Concerta used to treat ADHD may be less likely to be abused than other stimulant drugs

A team led by Massachusetts General Hospital (MGH) researchers has found that a delayed-release stimulant used to treat attention-deficit hyperactivity disorder (ADHD) may be less likely to be abused than other stimulant drugs.

1 Mar 2006

Ethnicity the most important personal characteristic in predicting complementary medicine use

A survey of older adults in rural North Carolina shows that they widely use complementary medicine therapies, but tend to focus on folk or home remedies, such as taking a daily "tonic" of vinegar or using Epsom salts.

1 Mar 2006

HAART is very cost-effective

New research shows that highly active antiretroviral therapy (HAART) is very cost-effective, despite the high price tag. However, the study also shows that reimbursement to physicians treating patients with HIV is critically low, threatening patients' access to care.

1 Mar 2006

Treatment of severe coronary artery disease with angioplasty/coronary stenting a viable alternative to bypass surgery

Severe stenosis (blockage) to the left main coronary artery - a condition commonly called a "widow-maker"- can result in sudden death. For nearly 30 years, the gold standard for treatment has been coronary artery bypass surgery (CABG).

1 Mar 2006

Association between body size and the built environment

Researchers at the Mailman School of Public Health are studying the link between the urban environment and how it might contribute to the cause or origins of obesity.

1 Mar 2006

Upsurge in diabetes-related deaths in New York City

Researchers at the Albert Einstein College of Medicine of Yeshiva University have documented a dramatic upsurge in diabetes-related deaths and illnesses in New York City - including a sharp increase in diabetic patients hospitalized with heart attacks.

1 Mar 2006

Many nursing home residents have poorly controlled pain due to inadequate medication treatment

Data revealed the mean total PMAS was 64 percent of optimal, suggesting a generally poor score. In fact, they found that less than half of residents with predictably recurrent pain were being prescribed scheduled pain medication; 23 percent received at least one high-risk medication.

1 Mar 2006

Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer

A new study shows that patients whose colorectal cancer has spread to the liver who received an approach called hepatic arterial infusion (HAI) - the administration of chemotherapy directly to the liver through a pump in the abdomen - fare better than those who received traditional, intravenous chemotherapy.

1 Mar 2006

$Hormone therapy for advanced prostate cancer can lead to bone loss and fractures$

Hormone therapy for advanced prostate cancer can lead to bone loss and fractures

A common type of treatment used to protect bone density in menopausal women is also an effective therapy for advanced prostate cancer patients during the first year of hormone therapy, according to a new Oregon Health & Science University Cancer Institute study.

1 Mar 2006

Visual clutter causes high-magnitude errors

Did you ever arrange to meet a friend at a busy street corner, then rush up to a total stranger thinking it was your friend?

1 Mar 2006

Compound found in marijuana may defend against diabetic retinopathy

A compound found in marijuana won't make you high but it may help keep your eyes healthy if you're a diabetic, researchers say.

1 Mar 2006

Cutaneous rabbit illusion affects human primary sensory cortex somatotopically

As much as neuroscientists know about the neural processes that signal touch, surprisingly little is understood about the neural correlates of conscious perception of tactile sensations.

1 Mar 2006

Celebrex safe for osteoarthritis

According to a study by Stanford University School of Medicine, Celebrex causes fewer gastrointestinal complications than traditional nonsteroidal anti-inflammatory painkillers or NSAIDs in osteoarthritis patients and does not increase the risk of heart attacks.

1 Mar 2006

Drug Trial News

Obese people may be more sensitive to pain

Reaction to DTaP vaccine finds no help from ibuprofen, acetaminophen

Physical symptoms that mark frailty often reversible

Amifostine makes radiation more effective

New technique provides insight into shape of DNA molecules attached to a surface

Human papillomavirus the main risk factor for cervical adenocarcinoma

Delayed surgical treatment may combat overtreatment of prostate cancer

Concerta used to treat ADHD may be less likely to be abused than other stimulant drugs

Ethnicity the most important personal characteristic in predicting complementary medicine use

HAART is very cost-effective

Treatment of severe coronary artery disease with angioplasty/coronary stenting a viable alternative to bypass surgery

Association between body size and the built environment

Upsurge in diabetes-related deaths in New York City

Many nursing home residents have poorly controlled pain due to inadequate medication treatment

Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer

Hormone therapy for advanced prostate cancer can lead to bone loss and fractures

Visual clutter causes high-magnitude errors

Compound found in marijuana may defend against diabetic retinopathy

Cutaneous rabbit illusion affects human primary sensory cortex somatotopically

Celebrex safe for osteoarthritis

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News